Scarica l'app Stockscreener
634.59
2.81%
17.39
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$617.20
Aprire:
$616.77
Volume 24 ore:
195.74K
Relative Volume:
0.37
Capitalizzazione di mercato:
$50.67B
Reddito:
$4.30B
Utile/perdita netta:
$1.06B
Rapporto P/E:
48.53
EPS:
13.076
Flusso di cassa netto:
$1.04B
1 W Prestazione:
-1.56%
1M Prestazione:
-11.13%
6M Prestazione:
-4.42%
1 anno Prestazione:
+38.02%
Intervallo 1D:
$606.04
$636.05
Intervallo di 1 settimana:
$606.04
$651.57
Portata 52W:
$356.14
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
634.59 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
TMO
Thermo Fisher Scientific Inc
|
506.51 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
213.13 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
A
Agilent Technologies Inc
|
125.74 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
321.08 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-10-31 | Aggiornamento | Stifel | Hold → Buy |
| 2025-10-01 | Iniziato | UBS | Neutral |
| 2025-08-05 | Reiterato | BTIG Research | Buy |
| 2025-07-01 | Iniziato | Jefferies | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
Agree To Purchase Idexx Laboratories At $560, Earn 8.5% Annualized Using Options - Nasdaq
Wealthfront Advisers LLC Buys 2,463 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories to Present at Two Institutional Investor Conferences - 01net
4,049 Shares in IDEXX Laboratories, Inc. $IDXX Purchased by Krilogy Financial LLC - MarketBeat
Rhumbline Advisers Reduces Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Caprock Group LLC Invests $5 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$7.34 Million in Common Stock - 富途牛牛
Insider Selling: IDEXX Laboratories (NASDAQ:IDXX) EVP Sells 11,345 Shares of Stock - MarketBeat
Baron Partners Fund is Leveraging IDEXX Laboratories’ (IDXX) Long-Term Growth Drivers - Insider Monkey
IDEXX Laboratories, Inc. $IDXX Shares Sold by Jensen Investment Management Inc. - MarketBeat
Midwest Trust Co Purchases 12,179 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Stock Position Decreased by RFG Advisory LLC - MarketBeat
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - Yahoo Finance
Aug Swings: Can IDEXX Laboratories Inc keep up with sector leadersJuly 2025 Breakouts & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
IDEXX Laboratories, Inc. $IDXX Shares Sold by ProShare Advisors LLC - MarketBeat
Candriam S.C.A. Has $14.68 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $750 - 富途牛牛
Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating - marketscreener.com
Oppenheimer Asset Management Inc. Sells 3,458 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
State of Michigan Retirement System Lowers Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory - Finviz
Envestnet Asset Management Inc. Trims Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Sold by IQ EQ FUND MANAGEMENT IRELAND Ltd - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Qiagen (QGEN) and InnovAge Holding (INNV) - The Globe and Mail
Is IDEXX’s Innovation-Fueled 2025 Results And 2026 Outlook Altering The Investment Case For IDXX? - Sahm
Barclays Adjusts Price Target on IDEXX Laboratories to $800 From $850, Maintains Overweight Rating - marketscreener.com
4 Analysts Have This To Say About IDEXX Laboratories - Benzinga
IDEXX Laboratories (IDXX) Positioned to Benefit from Growing Aging Pet Market - Finviz
Fidelity Growth Strategies Fund Avoids IDEXX Laboratories (IDXX) Due to Questionable Growth Durability - Insider Monkey
BI Asset Management Fondsmaeglerselskab A S Has $28.77 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Bessemer Group Inc. Sells 29,560 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Idexx Laboratories (IDXX) and West Pharmaceutical Services (WST) - The Globe and Mail
Barclays Lowers Price Target on IDEXX Laboratories to $800 From $850 - marketscreener.com
Idexx Laboratories executive vice president sells $4.6 million in stock - MSN
IDEXX: A Great Business Trapped By A Demanding Valuation (NASDAQ:IDXX) - Seeking Alpha
Hantz Financial Services Inc. Decreases Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Alta Capital Management LLC Cuts Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Atlantic Union Bankshares Corp Takes Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Rep. April McClain Delaney Sells Off Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Lonza Group (OtherLZAGY) - The Globe and Mail
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $730 to $805 - 富途牛牛
IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results - Benzinga
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $775 - 富途牛牛
Roku To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Jefferies Adjusts Price Target on IDEXX Laboratories to $820 From $830 - marketscreener.com
BTIG Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $800 - 富途牛牛
UBS Adjusts IDEXX Laboratories PT to $730 From $750 - marketscreener.com
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2025 earnings call transcript - MSN
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2025 Earnings Call Transcript - Insider Monkey
BTIG Adjusts Price Target on IDEXX Laboratories to $800 From $830 - marketscreener.com
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.71%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):